Mork Capital Management’s AbbVie ABBV Stock Holding History

Mork Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100,000	Closed	-$9.67M	–	99
2017 Q4	$9.67M	Hold	100,000	–	–	6.46%	1
2017 Q3	$8.89M	Hold	100,000	–	–	7.2%	1
2017 Q2	$7.25M	Hold	100,000	–	–	6.24%	1
2017 Q1	$6.52M	Hold	100,000	–	–	5.8%	1
2016 Q4	$6.26M	Hold	100,000	–	–	4.4%	1
2016 Q3	$6.31M	Hold	100,000	–	–	6.02%	1
2016 Q2	$6.19M	Hold	100,000	–	–	6.16%	1
2016 Q1	$5.71M	Buy	+100,000	New	+$5.57M	5.57%	1

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mork Capital Management's ABBV Position: Q1 2023 in Review

Mork Capital Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 7,530 shares — an estimated $1.22M sold.

Mork Capital Management first reported a position in ABBV in Q4 2015 and held it in 22 quarters. The position peaked at $2.38M in Q4 2020. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Mork Capital Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Mork Capital Management sold 7,530 AbbVie shares in Q1 2023, an estimated $1.22M.
Mork Capital Management first reported a position in AbbVie in Q4 2015 and held it in 22 quarters.
Mork Capital Management's AbbVie position peaked at $2.38M in Q4 2020.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Mork Capital Management's 13F filing for Q1 2023, filed 12 May 2023.